Charles River

For profitWebsite ↗

Also known as: Charles River Analytics | Charles River Biopharmaceutical Services GmbH | Charles River Clinical Research | Charles River Clinical Services Edinburgh Ltd and CR Laboratories Preclinical Services Ltd | Charles River Clinical Services, Edinburgh, UK | Charles River Clinical Services Northwest | Charles River Clinical Services Northwest Inc. | Charles River Clinical Services Northwest, Inc. | Charles River Labs | Charles River Northwestern Kinetics | Charles River Northwest Kinetics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Aug 1, 2007

Last known activity

Nov 1, 2016

Timeline

1940s

Jun 1, 1947
Charles River— Founded

2000s

Jul 1, 2004
Inveresk Research— Acquired
Oct 30, 2006
NW Kinetics— Acquired
Jun 1, 2007
Agilux— Acquired

2010s

Jul 9, 2015
Celsis International— Acquired
Nov 18, 2015
Oncotest— Acquired
Apr 4, 2016
WIL Research— Acquired
Jun 27, 2016
Blue Stream Laboratories— Acquired
Aug 7, 2017
Brains On-Line— Acquired
Jan 11, 2018
KWS BioTest— Acquired
Feb 13, 2018
MPI Research— Acquired
Feb 13, 2019
CiToxLAB— Acquired
Dec 16, 2019
HemaCare Corporation— Acquired

2020s

Feb 24, 2021
Cognate BioServices— Acquired
Mar 31, 2021
Retrogenix— Acquired
Jun 29, 2021
Vigene Biosciences— Acquired

Drugs by trial phase (29 distinct, 24 trials)

Phase 4 (0 own, 3 via acquisition)

Phase 2 (0 own, 4 via acquisition)

Phase 1 (7 own, 14 via acquisition)

Other trials (1 own, 0 via acquisition)

naratriptan

Indications

Studied for

Subsidiaries (15 direct, 16 total across the full acquisition tree)

Recent trials (9)

NCT03037788CollaboratorPhase 1Nov 1, 2016
NCT00879216Study directorPhase 1Apr 1, 2009
NCT00717262Overall official - principal investigatorPhase 1May 1, 2008
NCT00672984Overall official - principal investigatorPhase 1Apr 1, 2008
NCT00614016Overall official - principal investigatorPhase 1Jan 1, 2008
NCT00572611CollaboratorPhase 1Nov 1, 2007
NCT01161667Overall official - principal investigatorN/ASep 1, 2007
NCT00513994Overall official - principal investigatorPhase 1Aug 1, 2007
NCT01161654Overall official - principal investigatorN/AAug 1, 2007

Details

Founded: Wilmington, MA, US Jun 1, 1947
Last known activity: Nov 1, 2016